| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |